Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3078 studies found for:    "Hepatitis A"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis A"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Condition: Hepatitis A
Intervention: Biological: hepatitis A vaccine
2 Completed The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A
Condition: Hepatitis A
Interventions: Dietary Supplement: honey;   Dietary Supplement: molasses
3 Completed Hepatitis A Vaccination in the Elderly
Condition: Hepatitis A
Intervention:
4 Completed Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)
Condition: Hepatitis A
Intervention:
5 Completed A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Condition: Hepatitis A
Intervention: Biological: Hepatitis A vaccine
6 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
7 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
8 Completed Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents
Conditions: Hepatitis A;   Hepatitis A Virus
Intervention: Biological: Avaxim 80U Pediatric: Inactivated Hepatitis A Virus
9 Completed The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children
Condition: Hepatitis A
Interventions: Biological: Inactivated HAV vaccine;   Biological: Attenuated alive HAV vaccine
10 Completed
Has Results
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Condition: Hepatitis A
Interventions: Biological: HAVpur Junior;   Biological: Havrix 720 Junior
11 Withdrawn Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Condition: Hepatitis A
Intervention: Procedure: Blood sampling
12 Completed The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Attenuated HAV Vaccine, H2 Strain;   Biological: Attenuated HAV Vaccine, L-A-1 Strain;   Biological: Inactivated HAV Vaccine, Lu8 Strain;   Biological: Inactivated HAV Vaccine, TZ84 Strain
13 Completed Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Attenuated Hepatitis A Vaccine, H2 Strain;   Biological: Inactivated Hepatitis A Vaccine, Lu8 Strain;   Biological: Group A Meningococcal Polysaccharide vaccine
14 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
15 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
16 Completed Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine
Condition: Hepatitis A
Interventions: Biological: Healive® Lot 1;   Biological: Healive® Lot 2;   Biological: Healive® Lot 3;   Biological: Havrix
17 Completed Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Condition: Hepatitis A
Interventions: Biological: Epaxal;   Biological: Havrix 720
18 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
19 Completed Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Response to Hepatitis A Vaccine
Intervention: Biological: hepatitis A vaccine ( HAVRIX or EPAXAL)
20 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™ ADULT;   Biological: Engerix TM

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.